AquaBounty Technologies, Inc. (NASDAQ:AQB) Sees Significant Increase in Short Interest

AquaBounty Technologies, Inc. (NASDAQ:AQB) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 423,300 shares, an increase of 452.6% from the December 15th total of 76,600 shares. Based on an average daily volume of 425,500 shares, the days-to-cover ratio is presently 1.0 days. Currently, 11.7% of the company’s stock are short sold.

AquaBounty Technologies Stock Up 4.3 %

AQB traded up $0.03 during trading hours on Wednesday, hitting $0.80. 551,424 shares of the company’s stock were exchanged, compared to its average volume of 402,889. The company has a quick ratio of 2.98, a current ratio of 3.02 and a debt-to-equity ratio of 0.05. The stock’s 50-day moving average is $0.83 and its two-hundred day moving average is $1.13. The stock has a market cap of $3.10 million, a price-to-earnings ratio of -0.04 and a beta of 1.17. AquaBounty Technologies has a 1-year low of $0.47 and a 1-year high of $2.79.

AquaBounty Technologies (NASDAQ:AQB) last issued its quarterly earnings data on Tuesday, November 5th. The company reported ($0.88) earnings per share for the quarter, meeting the consensus estimate of ($0.88). AquaBounty Technologies had a negative net margin of 5,842.69% and a negative return on equity of 18.20%. The company had revenue of $0.05 million for the quarter, compared to analyst estimates of $0.10 million. During the same period in the prior year, the firm earned ($1.60) earnings per share. Sell-side analysts predict that AquaBounty Technologies will post -4.86 earnings per share for the current fiscal year.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.